acquiring Cubist. What's our take on the deal? Glaser: Merck is going to spend $9.5 billion for Cubist, and Damien Conover , our health-care analyst, thinks this is about expanding Merck's presence into the hospital acute-care segment
rest of 2014 might hold for M&A activity in health care, I recently talked with Morningstar health-care analysts Damien Conover , David Krempa, and Michael Waterhouse on May 31. Our discussion has been edited for clarity and length. Question
great competitive advantages. I'm here today with Damien Conover , our director of health-care research, to look ..... health-care space. Damien, thanks for joining me. Damien Conover : Thanks for having me, Jeremy. Glaser: You wrote
the coming years from other companies, so that growth will moderate. But they have a pretty strong pipeline, and Damien Conover , our [TICKER:JNJ] Johnson & Johnson analyst, really sees that their patent losses are pretty manageable
Unexpectedly robust sales of hepatitis C drug Olysio helped lift the drug giant’s pharma segment, while medical devices struggled, says Morningstar’s Damien Conover .
includes things like Claritin, Coppertone, and Dr. Scholl's foot insoles--and sending them over to Bayer. Damien Conover , our health-care analyst, thinks this is a good deal for both sides. Merck is getting a good price for these
AstraZeneca possibly having a deal. What's our take on this? Glaser: This deal likely makes a lot more sense. Damien Conover , our health-care analyst, sees [TICKER:AZN] AstraZeneca as having somewhat of the bloated cost structure
Cost-cutting, tax opportunities, and oncology synergies are motivating factors for Pfizer, and the firms will likely agree to merge, says Morningstar's Damien Conover .
The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover .
investments, the market, economic indicators, and more. Join us every day for fresh insights from our analyst team. Damien Conover : Today we're talking about health care, and when we think about health care, there are a lot of different industries